Scholarly open access journals, Peer-reviewed, and Refereed Journals, Impact factor 8.14 (Calculate by google scholar and Semantic Scholar | AI-Powered Research Tool) , Multidisciplinary, Monthly, Indexing in all major database & Metadata, Citation Generator, Digital Object Identifier(DOI)
In this study around the world, superbugs resistant to many drugs now pose a serious public health issue because few treatments remain effective. Bacteria like Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, along with Pseudomonas aeruginosa, often cause infections picked up in hospitals - these tend to worsen outcomes and lead to more deaths. At the frontlines of defence, macrophages clear pathogens through a process known as phagocytosis, helping protect the body from day one. Still, some MDR bacteria might outsmart the body's clean-up cells. This research looks at how well immune fighters grab and destroy different types of drug-resistant versus regular bacteria found in patients. Bacteria samples come from real cases, checked by usual lab methods to confirm their presence. After finding which ones are present, tests with antibiotics show which resist multiple drugs. A lab-based setup involving macrophage cells grown from lines will be created through differentiation. Measuring how these cells take in particles involves tracking the phagocytic index along with bacterial survival inside them. Instead of just guessing, actual counts using CFU analysis after gentamicin treatment give clear numbers. On top of that, measuring ROS levels shows whether oxidative bursts happen as expected. Looking at the results, differences in how macrophages clear MDR compared to non-MDR bacteria might come into view, offering clues about behaviour between host and germ. One outcome could be new angles on how immunity works when pathogens adapt. Such work may later feed into exploring macrophages as a back-up way to fight drug-resistant infections.
"Comparative Analysis of Macrophage Phagocytic Efficiency Against Multidrug-Resistant Clinical Bacterial Isolates", International Journal for Research Trends and Innovation (www.ijrti.org), ISSN:2456-3315, Vol.11, Issue 2, page no.b263-b272, February-2026, Available :http://www.ijrti.org/papers/IJRTI2602135.pdf
Downloads:
00079
ISSN:
2456-3315 | IMPACT FACTOR: 8.14 Calculated By Google Scholar| ESTD YEAR: 2016
An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 8.14 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator